Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
Authors
Keywords
miR-193a-5p, Prostate cancer, Docetaxel, Chemoresistance, HO-1, Bach2
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 36, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-08
DOI
10.1186/s13046-017-0649-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Docetaxel Activity in the Era of Life-prolonging Hormonal Therapies for Metastatic Castration-resistant Prostate Cancer
- (2016) Edoardo Francini et al. EUROPEAN UROLOGY
- SUMOylation of KLF4 acts as a switch in transcriptional programs that control VSMC proliferation
- (2016) Chan-juan Nie et al. EXPERIMENTAL CELL RESEARCH
- The transcription factor BACH2 promotes tumor immunosuppression
- (2016) Rahul Roychoudhuri et al. JOURNAL OF CLINICAL INVESTIGATION
- miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors
- (2016) Camille Jacques et al. Oncotarget
- Polyphenol-rich Avicennia marina leaf extracts induce apoptosis in human breast and liver cancer cells and in a nude mouse xenograft model
- (2016) Cheng Huang et al. Oncotarget
- MiR-193a-5p Targets the Coding Region of AP-2α mRNA and Induces Cisplatin Resistance in Bladder Cancers
- (2016) Ji Zhou et al. Journal of Cancer
- miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
- (2015) X.-B. Shi et al. CANCER RESEARCH
- Demethylation of the miR-146a promoter by 5-Aza-2’-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer
- (2014) Xiaolu Wang et al. BMC CANCER
- miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway
- (2014) Hui Deng et al. Molecular Cancer
- PPARα Activation Sensitizes Cancer Cells to Epigallocatechin-3-Gallate (EGCG) Treatment via Suppressing Heme Oxygenase-1
- (2014) Shuyu Zhang et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway
- (2014) T Yu et al. ONCOGENE
- miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells
- (2013) Marzia Pennati et al. BIOCHEMICAL PHARMACOLOGY
- High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
- (2013) Suvi-Katri Leivonen et al. Molecular Oncology
- BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint
- (2013) Srividya Swaminathan et al. NATURE MEDICINE
- Comprehensive microRNA Profiling of Prostate Cancer
- (2013) Beatriz A. Walter et al. Journal of Cancer
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma
- (2012) Y Yang et al. ONCOGENE
- Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
- (2011) Lucy Heinemann et al. BMC CANCER
- Antitumor promoting potential of selected phytochemicals derived from spices
- (2011) Shashi Rajput et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells
- (2011) Kati H. Pulkkinen et al. FREE RADICAL BIOLOGY AND MEDICINE
- PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome
- (2011) Yunru Li et al. JOURNAL OF PATHOLOGY
- Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
- (2010) Guo-hai Shi et al. ACTA PHARMACOLOGICA SINICA
- Class III -Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy
- (2010) G. Ploussard et al. CANCER RESEARCH
- Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites
- (2010) Doron Betel et al. GENOME BIOLOGY
- A Novel Experimental Heme Oxygenase-1-Targeted Therapy for Hormone-Refractory Prostate Cancer
- (2009) M. A. Alaoui-Jamali et al. CANCER RESEARCH
- Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer
- (2009) Akihiro Matsumoto et al. INTERNATIONAL JOURNAL OF UROLOGY
- Chemosensitization of Cancer by Nitric Oxide
- (2008) Richard Sullivan et al. CURRENT PHARMACEUTICAL DESIGN
- Upregulation of Heme Oxygenase-1 Expression in Areca-quid-chewing-associated Oral Squamous Cell Carcinoma
- (2008) Shiuan-Shinn Lee et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio
- (2008) Shannon Reagan-Shaw et al. PROSTATE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search